OR WAIT 15 SECS
© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
November 12, 2020
Results of 2 recent studies suggested a higher risk of developing osteoporosis in patients with inflammatory bowel disease.
November 11, 2020
An overview of the use of satralizumab-mwge (Enspryng; Genentech) in neuromyelitis optica spectrum disorder (NMOSD).
September 22, 2020
Two lots of the thyroid tablets are being recalled after testing found the lots to be subpotent.
September 11, 2020
Higher cumulative exposure to systemic antibiotic therapy may be associated with a greater risk of new-onset inflammatory bowel disease.
September 10, 2020
Pharmacists can play an important role in educating patients about autoimmune drugs to prevent medication errors.
August 21, 2020
Levodopa/carbidopa is currently the gold standard for controlling motor symptoms associated with Parkinson disease.
August 20, 2020
Ofatumumab (Kesimpta; Novartis) is the first and only self-administered, targeted B-cell therapy for the treatment of relapsing multiple sclerosis.
August 18, 2020
The therapy received fast track designation and was approved in just over 1 year.
August 14, 2020
A Kawasaki-like inflammatory disease has affected children who have coronavirus disease 2019.
July 13, 2020
The data from a new study has shown that investigational, long-acting injectable cabotegravir boasted a 66% higher efficacy than daily oral pills in preventing HIV-1.